Making NIH Heart and Stroke Research a National Priority
|Advocates discussed the need for increased NIH funding with Congress during the association's lobby day in 2013.|
Although remarkable progress has been made in the fight against cardiovascular disease, there is no cure for America’s No. 1 and most costly killer. Robust research, funded by the National Institutes of Health (NIH), remains our country’s best hope for discovering innovative ways to prevent, treat and find cures for heart disease and stroke.
That’s why the association is urging Congress to make NIH-supported heart and stroke research a national priority. Currently, the NIH invests just four percent of its budget on heart research and a mere one percent on stroke research. These funding levels do not correspond to research opportunities, the number of Americans afflicted or the economic toll of cardiovascular disease. As our nation’s population ages, nearly 44 percent of Americans are likely to face some form of cardiovascular disease by 2030, and the cost of heart disease is expected to increase from $579 billion to $1.208 trillion by 2030.
The NIH needs $33 billion to restore a 20 percent loss in purchasing power it has experienced over the past decade because of medical research inflation. This shortfall comes at a time when other countries are doubling their investment in science. Without the 10 percent increase to the agency’s budget our nation will miss out on a time of unprecedented scientific opportunities that could help save lives, support jobs, spur economic growth, drive innovation and preserve U.S. leadership in medical research.
Now is not the time to slash the NIH funding needed to support live-saving medical discoveries. Federal support for NIH is an investment in our country’s future.